Healthy volunteers with stiff shoulders
Conditions
Interventions
Intervention, group A NKCP 250 mg/day for 4 weeks A washout period for 4 weeks placebo for 4 weeks
Intervention, group B placebo for 4 weeks A washout period for 4 weeks NKCP 250 mg/day for 4 we
Sponsors
University of Shizuoka
Seirei Health Support-Center Shizuoka SBS Shizuoka Health Promotion Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: The healthy volunteers with stiff shoulder
Exclusion criteria
Exclusion criteria: 1) The person with underlying disease 2) Pregnancy and nursing 3) Cognitive impairment 4) The person who uses the supplement which influence stiff shoulder 5) The person who participates in other clinical trials at the time of this study entry 6) etc
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Stiff shoulder and shoulder pain were evaluated using the pain visual analog scale (VAS). 2. Shoulder joint flexibility was evaluated using Shoulder 36 Ver.1.3. 3. Shoulder stiffness was measured by muscular tissue hardness meter. These experiments were performed at preinitiation period and after 4, 8, and 12 weeks. | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood pressure, plus rate The measurement of swelling of a foot The measurement of blood flow and thermographic analysis around shoulder The measurement of tiredness These experiments were performed at preinitiation period and after 4, 8, and 12 weeks. | — |
Countries
Japan
Contacts
Public ContactYoichi Sunagawa
University of Shizuoka Division of Molecular Medicine, School of Pharmaceutical Sciences
Outcome results
None listed